&w=3840&q=100)
Torrent Pharma bucks weak market trend; rallies 3%, hits record high
Torrent Pharma share price today
Shares of Torrent Pharmaceuticals hit a record high of ₹3,612.20, as they rallied 3 per cent on the BSE in Friday's intra-day trade in an otherwise weak market. The stock price of the pharmaceutical company surpassed its previous high of ₹3,589.95 touched on October 10, 2024. In comparison, the BSE Sensex was down 0.74 per cent at 81,579 at 01:59 PM.
In the past one month, Torrent Pharmaceuticals has outperformed the market by surging 12 per cent. In comparison, the BSE Sensex was down 1.4 per cent, while, BSE Healthcare index gained 4 per cent during the period. CATCH STOCK MARKET LIVE UPDATES TODAY
Q1FY26 results on Monday, July, 28, 2025
The board of directors of Torrent Pharmaceuticals will meet on Monday, July 28, 2025 to consider and approve the audited financial results of the company for the quarter ended on June 30, 2025 (Q1FY26).
Torrent - JB Chemicals Pharmaceuticals (JBCP) deal
On June 29, 2025, Torrent Pharmaceuticals announced a major strategic move with the acquisition of a controlling 46.4 per cent stake in JB Chemicals & Pharmaceuticals (JBCP) for ₹11,920 crore at ₹1,600 per share from the promoter Tau Investment Holdings or KKR. In addition, the company launched an open offer for a further 26 per cent at ₹1,639.18 per share and intends to merge JBCP within itself through a court-approved scheme.
This represents Torrent Pharma's largest-ever acquisition and positions it as a stronger firm in India's branded generics landscape, with deeper reach across therapeutic areas and geographies.
Torrent's deep India presence and JBCP's fast growing India business, combined with the Contract Development and Manufacturing Organization (CDMO) and international footprint offers immense potential to scale both revenue and profitability. This strategic alignment furthers Torrent's goal of strengthening the company's presence in the Indian pharma market, and build a larger diversified global presence. Moreover, the CDMO platform provides a new long-term avenue of growth for Torrent.
The combined entity would operate at ₹15,400 crore revenue base with a broader branded portfolio and expanded international presence. While the acquisition premium is steep, long-term value creation hinges on efficient integration, synergy realization, and sustained growth across domestic and global businesses, according to analysts at Elara Capital.
Way Forward
Moving ahead, Torrent Pharma in its FY25 annual report said that the company's focus will be on consolidating and strengthening its leadership position in the branded generic segment.
In India, the company will focus on strengthening its leadership in key therapy areas, expanding consumer health portfolio, and enhancing field force productivity to capture untapped opportunities. In the international markets, the company anticipates continued growth in Brazil, driven by recent successful launches and a robust pipeline awaiting regulatory approvals. In Germany, new tender wins are expected to support revenue growth despite some challenges in the OTC segment. The US market remains stable, with a focus on maintaining compliance and a strong product pipeline, the company said.
India-UK Free Trade to benefit pharma companies
The India-UK Free Trade Agreement is set to boost India's pharma Industry by expanding market access for generics and biosimilars, fast-tracking approvals, and encouraging cross-border R&D. It also enables collaborations in bulk drug imports and CDMO. While most pharma exports to the UK were already duty-free, the UK's commitment to zero tariffs on 99 per cent of exports formalises this, offering long-term clarity. Pharma exports to the UK stood at ~US$910 million in FY24, ICICI Securities said in a note.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Today
27 minutes ago
- India Today
Brigade Hotel Ventures IPO allotment: Step-by-step guide to check status
The share allotment for Brigade Hotel Ventures IPO is expected to be finalised on Tuesday, July 29, 2025. The public issue, which opened for subscription on July 24 and closed on July 28, received a decent response from investors across to stock exchange data, the IPO was subscribed 4.76 times overall. The retail investor portion was subscribed 6.83 times, while the Qualified Institutional Buyer (QIB) category was subscribed 5.74 times. The Non-Institutional Investor (NII) portion saw a 2.03 times subscription by the close of bidding on July who applied for shares can check their allotment status either on the Bombay Stock Exchange (BSE) website or through the portal of KFin Technologies Limited, the official registrar for this TO CHECK ALLOTMENT STATUS ON BSEGo to the BSE IPO allotment status "Equity" under the Issue "Brigade Hotel Ventures IPO" from the Issue Name your Application your PAN Card the captcha on "Search" to see your allotment KFIN TECHNOLOGIESVisit the IPO status section on KFin Technologies' official "Brigade Hotel Ventures IPO" from the a method to check your status: Application Number, Demat Account Number, or Application Type – ASBA or the details as the "Submit" to view your GMP AND EXPECTED LISTINGAs of July 29, 2025, the last updated Grey Market Premium (GMP) for Brigade Hotel Ventures IPO stands at Rs 0. Based on the price band of Rs 90, the estimated listing price is also Rs 90. This means there is currently no expected gain or loss per share on Hotel Ventures is expected to be listed on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE). The tentative listing date is Thursday, July 31, 2025.- Ends
Hans India
an hour ago
- Hans India
Key indices slip to 2-mth low
Mumbai: Falling for the third straight session on Monday, benchmark Sensex tumbled by 572 points to close at nearly a two-month low due to heavy selling in Kotak Mahindra Bank, forex outflows and uncertainty related to the India-US trade deal. The 30-share BSE barometer tanked 572.07 points or 0.70 per cent to settle at 80,891.02, a level not seen since June 4. During the day, it slumped 686.65 points or 0.84 per cent to 80,776.44. The 50-share NSE Nifty declined 156.10 points or 0.63 per cent to close at a nearly two-month low of 24,680.90. As many as 35 Nifty shares declined, and 15 advanced. Analysts said disappointing quarterly results and continued selling by FIIs dragged stock markets down for the third session in a row. Nifty has tanked over 2 per cent or 539 points while Sensex retreated by 1,835 points or 2.2 per cent to trade at near two-month low levels. Among Sensex firms, Kotak Mahindra Bank tumbled the most by 7.31 per cent after the company reported a consolidated net profit of Rs 4,472 crore for the June quarter, and flagged stress on the retail commercial vehicle portfolio due to adverse macroeconomic conditions. The profit in the year-ago period was Rs 7,448 crore, but it had included gains of over Rs 3,000 crore on its stake sale in the general insurance arm, while the net profit for the March quarter stood at Rs 4,933 crore. Bajaj Finance dropped 3.64 per cent amid asset quality concerns, while Bharti Airtel fell by 2.35 per cent. Tata Consultancy Services dropped 1.76 per cent amid reports that the IT major has decided to lay off over 12,000 employees. Sources said that the IT Ministry is keeping a close watch on the entire situation and is in touch with the tech company over the matter. Titan, HCL Tech and State Bank of India were also among the laggards. However, Hindustan Unilever, Asian Paints, ICICI Bank, Power Grid, HDFC Bank and ITC were the gainers. 'Domestic market sentiment has remained cautious, weighed down by a disappointing set of Q1 earnings, delays in the India-US trade agreement, and continued FII outflows. In contrast, global markets remain broadly positive, supported by US-EU trade developments that are perceived as less concerning than anticipated. 'The upcoming monetary policy decisions from the Fed and BoJ, along with the trajectory of domestic quarterly earnings, are expected to play a pivotal role in shaping market direction in the near term,' Vinod Nair, Head of Research, Geojit Investments Limited, said. The BSE smallcap gauge tumbled 1.31 per cent and midcap index fell by 0.73 per cent. Among BSE sectoral indices, realty tanked 4.11 per cent, followed by telecommunication (1.56 per cent), capital goods (1.49 per cent), BSE industrials (1.40 per cent), teck (1.21 per cent) and metal (1.06 per cent).
Mint
an hour ago
- Mint
Q1 results today: NTPC, L&T, Asian Paints, Varun Beverages, BOI, Dilip Buildcon to release earnings on July 29
Q1 results today, on July 29: NTPC, L&T, Asian Paints, New India Assurance, Bank of India, Varun Beverages, Deepak Fertilisers, Dilip Buildcon, and Blue Dart are among at least 21 other companies set to release earnings reports today on July 29 (Tuesday). Overall, over 100 firms are listed to announce their Q1FY26 results during the week of July 28-August 2. These include big names such as IndusInd Bank, Asian Paints, NTPC, Tata Steel, Hindustan Unilever, Mahindra & Mahindra, Maruti Suzuki, Sun Pharma, and ITC among others. Investors are keenly watching these for corporate announcements, forward looking statements, revenue outlooks, and share prices, to make calculated investment decisions. At least 21 companies are set to release their Q1 earnings on Tuesday, July 29. These include many public sector (PSU) heavyweights such as NTPC, New India Assurance, and Bank of India and private marquee companies such as L&T, Asian Paints, Varun Beverages, Deepak Fertilisers, Dilip Buildcon, and Blue Dart. Firms releasing their earnings today include, Larsen & Toubro, Asian Paints, NTPC, GE Vernova TD India, Varun Beverages, Apar Industries, Bank of India, Piramal Enterprises, New India Assurance Company, Star Health & Allied Insurance Company, Welspun Corp, Jubilant Pharmova, Deepak Fertilisers And Petrochemicals Corporation, International Gemmological Institute India, Gallantt Ispat, Blue Dart Express, Gabriel India, Allied Blenders & Distillers, Happiest Minds Technologies, Strides Pharma Science, and Dilip Buildcon, among others. The Indian stock market's benchmark indices, Sensex and Nifty, are expected to open on a tepid note today, tracking weak global market cues; while trends on Gift Nifty also indicate a muted start. The Gift Nifty was trading around 24,672 level, a discount of nearly 38 points from the Nifty futures' previous close. Notably, on July 28, the Sensex ended with sharp losses, and the benchmark Nifty 50 closed below 24,700 level. The Sensex cracked 572.07 points, or 0.70 per cent, to close at 80,891.02, while the Nifty 50 settled 156.10 points, or 0.63 per cent, lower at 24,680.90. According to Shrikant Chouhan, Head – Equity Research at Kotak Securities, '…As long as Sensex is trading below 81,100, the weak sentiment is likely to continue. On the downside, the index may correct until 80,500-80,350. On the upside, a break above 81,100 could lead to a pullback rally extending up to 81,400. Further upside may also continue, potentially pushing Sensex up to 81,700.' On Nifty, Nagaraj Shetti, Senior Technical Research Analyst at HDFC Securities feels that the underlying trend remains weak and one may expect some more declines in the coming sessions. 'The next crucial lower supports to be watched are around 24,500, while immediate resistance is placed at 24,800,' he stated. Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.
